306 |
Outcomes After TAVR in Bicuspid Aortic Stenosis: US/EU data |
Raj Makkar |
Jul. 21. 21 |
305 |
TAVR for Bicuspid AS: Optimal Sizing & Valve Selection |
Jung-Min Ahn |
Jul. 21. 21 |
304 |
International BASILICA and CHIMNEY Registry Results |
Ron Waksman |
Jul. 21. 21 |
303 |
Bioprosthetic Valve Fracture for Optimization of Valve-in-Valve: When, Why, and How? |
David Joel Cohen |
Jul. 21. 21 |
302 |
Tricuspid Valve |
Thomas Modine |
Jul. 21. 21 |
301 |
How to Optimize Sapien 3 Implantation for Future Management: FCA, Bicuspid, ViV, Low risk AS |
Duk-Woo Park |
Jul. 21. 21 |
300 |
Small Annuli and Sapien 3: Clinical Outcome |
Daisuke Hachinohe |
Jul. 21. 21 |
299 |
Nothing is Complete Unless You Put Standard in Your Demand: Superior to Surgery in LR, PVL, PPI |
Jung-Hee Lee |
Jul. 21. 21 |
298 |
CT for TMVR Planning: Imaging Specialist's Tips and Tricks |
Philipp Blanke |
Jul. 21. 21 |
297 |
LAAO Challenging Cases : Advanced Techniques and New Devices |
Philippe Garot |
Jul. 21. 21 |